The company is presenting several abstracts during the five-day conference showcasing clinical and real-world evidence that support the benefits of its products. Dexcom is presenting several abstracts ...
Dexcom posted first-quarter 2026 results ahead of Wall Street expectations, with revenue up 15% to $1.19 billion and adjusted EPS of $0.56. The company raised its operating and EBITDA margin outlooks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results